Renowned billionaire investor and owner of the NY Mets, Steve Cohen, continues to show his support for the biopharmaceutical sector by purchasing over 119 million shares of Bionomics Limited, a leading clinical-stage biopharma company. This move further solidifies Cohen’s commitment to investing in promising biotech companies. 10/2